Algry Quimica Expanding Choline Manufacturing

Algry Quimica Expanding Choline Manufacturing

MADRID--Algry Quimica reported its sales of humancholine salts were up 35 percent in the first quarter, and 2002 annual sales areexpected to be 70-percent higher than 2001. To keep up with demand, the companyis expanding its manufacturing capabilities by approximately 80 percent in itsHuelva, Spain, choline salts facility.

"The market for choline derivatives has experiencedsignificant growth in recent years, and especially since the FDA's recentdecision authorizing products containing qualifying amounts of choline to carrya nutrient label," said Guillermo Rodriguez, sales manager of Algry Quimica(www.algry.com). "We also expect thisgrowth trend to be maintained during 2003, since interest in the newest vitaminis growing, especially in the United States."